Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol extended-release oral suspension in lower respiratory tract disease with viscous sputum
CTR20130826Phase 2Active
- Sponsor
- Sanrun Medical
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ambroxol in pulmonary infection, sponsored by Sanrun Medical. Started May 2014; status: active.
02
Drugs
ambroxol
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on CTR20130826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130826.